阿奇霉素与罗红霉素预防慢性阻塞性肺疾病急性发作的效果比较

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (39 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the clinical effect of Azithromycin and Roxithromycin in preventing acute attack of chronic obstructive pulmonary disease.Methods A total of 80 patients with chronic obstructive pulmonary disease admitted to Affiliated Zhongshan Hospital of Dalian University from February 2019 to May 2020 were selected as the research objects,and they were divided into the control group and the observation group according to the random number table method,with 40 cases in each group.The observation group was treated with Roxithromycin,the control group was treated with Azithromycin,both groups were treated for 1 week.The changes of St George′s respiratory question(SGRQ) scores were compared before treatment,3 d after treatment and 1 week after treatment,inflammatory indexes(tumor necrosis factor-α[TNF-α],high-sensitivity C-reactive protein[hs-CRP]),pulmonary function indexes (percentage of forced expiratory volume in first second to forced vital capacity[FEV1%]and forced expiratory volume in one second/forced vital capacity[FEV1/FVC]) before and after treatment and the occurrence of adverse reactions were compared between the two groups.Results After treatment for 3 days and 1 week,the SGRQ scores in both groups were lower than those before treatment,and the SGRQ score of the observation group was lower than that of the control group,the differences were statistically significant (P＜0.05).After treatment,the levels of TNF-α and hs-CRP in both groups were lower than those before treatment,and the levels of TNF-α and hs-CRP in the observation group were lower than those in the control group,the differences were statistically significant (P＜0.05).After treatment,the levels of FEV1% and FEV1/FVC in both groups were higher than those before treatment,and the levels of FEV1% and FEV1/FVC in the observation group were higher than those in the control group,the differences were statistically significant(P＜0.05).The total incidence of gastrointestinal discomfort,rash,bitter mouth and tinnitus in the observation group was lower than that in the control group,the difference was statistically significant (P＜0.05).Conclusion The use of Roxithromycin to prevent the acute attack of chronic obstructive pulmonary disease can effectively improve the clinical symptoms of patients,reduce inflammation,improve lung function,with fewer adverse reactions and high safety.

Key words： Azithromycin Roxithromycin Chronic obstructive pulmonary disease Acute attack

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Xiao-yun
	TANG Xiao-xiao

Cite this article:

CHEN Xiao-yun,TANG Xiao-xiao. Comparison of the effect of Azithromycin and Roxithromycin in preventing acute attack of chronic obstructive pulmonary disease[J]. 中国当代医药, 2021, 28(1): 46-49.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I1/46

[1]	魏胜全，薛华，王惠霞，等.罗红霉素联合N-乙酰半胱氨酸治疗慢性阻塞性肺疾病合并肺间质纤维化疗效及对患者肺功能的影响[J].陕西医学杂志，2020，49（5）：611-614.
[2]	史永红.小剂量罗红霉素口服治疗支气管扩张的长期疗效研究[J].北方药学，2020，17（4）：97-98.
[3]	李森，张霞，任敏，等.小剂量罗红霉素联合沙美特罗替卡松治疗老年支气管扩张的临床效果[J].临床医学研究与实践，2020，5（8）：51-53.
[4]	王海劲，梁文焕，黄燕萍，等.长期小剂量罗红霉素联合匹多莫德对支气管扩张治疗的临床疗效观察[J].赣南医学院学报，2020，40（1）：83-85，98.
[5]	王建，王紫汀，朱莉，等.沙美特罗替卡松联合罗红霉素治疗老年支气管扩张[J].国际老年医学杂志，2020，41（1）：27-28，61.
[6]	中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.慢性阻塞性肺疾病基层诊疗指南(2018年)[J].中华全科医师杂志，2018，17（11）：856-870.
[7]	陈芳.小剂量罗红霉素对支气管哮喘患儿细胞免疫功能及炎症因子水平的影响[J].新乡医学院学报，2020，37（1）：68-71.
[8]	付祥玲.小剂量罗红霉素治疗支气管扩张患者的临床效果分析[J].国际感染病学（电子版），2019，8（4）：143.
[9]	陈更业，马玉龙，郭瑞娟，等.噻托溴铵粉吸入剂联合罗红霉素治疗稳定期支气管扩张症患者的疗效及对免疫功能的影响[J].中国全科医学，2019，22（S2）：70-72.
[10]	邹琴，王博龙.长期小剂量罗红霉素对稳定期慢性阻塞性肺疾病疗效作用的Meta 分析[J].中国抗生素杂志，2019，44（4）：510-518.
[11]	蒋亚林，荣令，唐超，等.比较阿奇霉素与罗红霉素在预防慢性阻塞性肺疾病急性加重中的作用及不良反应[J].国际呼吸杂志，2018，38（16）：1220-1224.
[12]	洪琳，冯建华，洪瑛，等.稳定期慢性阻塞性肺疾病患者口服阿奇霉素和罗红霉素的疗效、肺功能及炎性因子的对比研究[J].药物评价研究，2019，42（7）：1398-1402.
[13]	耿军辉.小剂量罗红霉素治疗慢性阻塞性肺疾病稳定期的临床疗效[J].中西医结合心血管病电子杂志，2018，6（5）：43-44.
[14]	刘懿颖.小剂量罗红霉素辅助治疗慢性阻塞性肺疾病合并鼻窦炎效果观察[J].中国乡村医药，2017，24（22）：33-34.
[15]	陈银花，张启确，陈春梅.小剂量罗红霉素与长效茶碱对重度慢性阻塞性肺疾病患者稳定期的临床疗效比较[J].抗感染药学，2016，13（5）：1113-1115.
[16]	温泳涛，王兆邦，谢衬梨，等.探讨慢性阻塞性肺疾病采用罗红霉素联合噻托溴铵治疗的临床价值[J].中国医学工程，2016，24（7）：92-94.
[17]	郑瑞兵，彭卫东.罗红霉素治疗慢性阻塞性肺疾病稳定期患者气道炎症疗效观察[J].中国药师，2016，19（7）：1334-1336.